Manufacturing Cures: Infrastructure Challenges Facing Cell And Gene Therapy Developers

To Ensure Broad Patient Access To Cell And Gene Therapies Stakeholders Must Address Manufacturing Challenges

regenerative-medicine
The supply chain for managing new cell and gene therapies is incredibly complex • Source: Shutterstock

More from Market Intelligence

More from In Vivo